Identification and characterization of intracellular proteins that bind oligonucleotides with phosphorothioate linkages

Nucleic Acids Research

Volumn 43, Issue 5, 2015, Pages 2927-2945

  Liang, Xue Hai ^a   Sun, Hong ^a   Shen, Wen ^a   Crooke, Stanley T ^a  

^a ISIS PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; ANXA2 PROTEIN; BINDING PROTEIN; CELL PROTEIN; LA ANTIGEN; NUCLEOPHOSMIN; OLIGONUCLEOTIDE; PC4 PROTEIN; PHOSPHOROTHIOIC ACID; PROTEIN; RIBONUCLEASE H; RNA; UNCLASSIFIED DRUG; VARS PROTEIN; ANXA2 PROTEIN, HUMAN; CELL NUCLEUS ANTIGEN; DNA BINDING PROTEIN; KU ANTIGEN; LA PROTEIN, HUMAN; LIPOCORTIN 2; NUCLEAR PROTEIN; PHOSPHOPROTEIN; PROTEIN BINDING;

ARTICLE; BINDING AFFINITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOCYTOSIS; GENE EXPRESSION; HUMAN; HUMAN CELL; LYSOSOME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN LOCALIZATION; CONFOCAL MICROSCOPY; CYTOPLASM; GENETICS; HEK293 CELL LINE; HELA CELL LINE; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING;

ANNEXIN A2; ANTIGENS, NUCLEAR; BLOTTING, WESTERN; CYTOPLASM; DNA-BINDING PROTEINS; HEK293 CELLS; HELA CELLS; HUMANS; MICROSCOPY, CONFOCAL; NUCLEAR PROTEINS; OLIGONUCLEOTIDES, ANTISENSE; PHOSPHOPROTEINS; PROTEIN BINDING; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA INTERFERENCE;

EID: 84936790721     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkv143     Document Type: Article

References (47)

1. Lima, W., Wu, H. and Crooke, S. T. (2008) The RNase H Mechanism. In: Crooke, ST (ed). Antisense Drug Technology-Principles, Strategies, and Applications. 2nd edn. CRC Press, Boca Raton, FL, pp. 47-74.
2. Crooke, S. T., Vickers, T. A., Lima, W. F. and Wu, H.-J. (2008) Mechanisms of Antisense Drug Action, an Introduction. In: Crooke, ST (ed). Antisense Drug Technology-Principles, Strategies, and Applications. 2nd edn. CRC Press, Boca Raton, FL, pp. 3-46.
3. Watts, J. K. and Corey, D. R. (2012) Silencing disease genes in the laboratory and the clinic. J. Pathol., 226, 365-379.
4. Nowotny, M., Gaidamakov, S. A., Crouch, R. J. and Yang, W. (2005) Crystal structures of RNase H bound to an RNA/DNA hybrid: substrate specificity and metal-dependent catalysis. Cell, 121, 1005-1016.
5. Wu, H., Lima, W. F., Zhang, H., Fan, A., Sun, H. and Crooke, S. T. (2004) Determination of the role of the human RNase H1 in the pharmacology of DNA-like antisense drugs. J. Biol. Chem., 279, 17181-17189.
6. Wu, H., Sun, H., Liang, X., Lima, W. F. and Crooke, S. T. (2013) Human RNase H1 is associated with protein P32 and is involved in mitochondrial pre-rRNA processing. PLoS One, 8, e71006.
7. Bennett, C. F. and Swayze, E. E. (2010) RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform. Annu. Rev. Pharmacol. Toxicol., 50, 259-293.
8. Marcusson, E. G., Bhat, B., Manoharan, M., Bennett, C. F. and Dean, N. M. (1998) Phosphorothioate oligodeoxyribonucleotides dissociate from cationic lipids before entering the nucleus. Nucleic Acids Res., 26, 2016-2023.
9. Koller, E., Vincent, T. M., Chappell, A., De, S., Manoharan, M. and Bennett, C. F. (2011) Mechanisms of single-stranded phosphorothioate modified antisense oligonucleotide accumulation in hepatocytes. Nucleic Acids Res., 39, 4795-4807.
10. Beltinger, C., Saragovi, H. U., Smith, R. M., Le Sauteur, L., Shah, N., De Dionisio, L., Christensen, L., Raible, A., Jarett, L. and Gewirtz, A. M. (1995) Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides. J. Clin. Invest., 95, 1814-1823.
11. Juliano, R. L., Ming, X. and Nakagawa, O. (2012) Cellular uptake and intracellular trafficking of antisense and siRNA oligonucleotides. Bioconjug. Chem., 23, 147-157.
12. Juliano, R. L., Carver, K., Cao, C. and Ming, X. (2013) Receptors, endocytosis, and trafficking: the biological basis of targeted delivery of antisense and siRNA oligonucleotides. J. Drug Targ., 21, 27-43.
13. Stein, C. A., Hansen, J. B., Lai, J., Wu, S., Voskresenskiy, A., Hog, A., Worm, J., Hedtjarn, M., Souleimanian, N., Miller, P. et al. (2010) Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents. Nucleic Acids Res., 38, e3.
14. Dias, N. and Stein, C. A. (2002) Antisense oligonucleotides: basic concepts and mechanisms. Mol. Cancer Ther., 1, 347-355.
15. Bennett, C. F., Chiang, M. Y., Chan, H., Shoemaker, J. E. and Mirabelli, C. K. (1992) Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol. Pharmacol., 41, 1023-1033.
16. Lorenz, P., Misteli, T., Baker, B. F., Bennett, C. F. and Spector, D. L. (2000) Nucleocytoplasmic shuttling: a novel in vivo property of antisense phosphorothioate oligodeoxynucleotides. Nucleic Acids Res., 28, 582-592.
17. Hartig, R., Shoeman, R. L., Janetzko, A., Grub, S. and Traub, P. (1998) Active nuclear import of single-stranded oligonucleotides and their complexes with non-karyophilic macromolecules. Biol. Cell, 90, 407-426.
18. Lima, W. F., Vickers, T. A., Nichols, J., Li, C. and Crooke, S. T. (2014) Defining the factors that contribute to on-target specificity of antisense oligonucleotides. PLoS One, 9, e101752.
19. Brown, D. A., Kang, S. H., Gryaznov, S. M., De Dionisio, L., Heidenreich, O., Sullivan, S., Xu, X. and Nerenberg, M. I. (1994) Effect of phosphorothioate modification of oligodeoxynucleotides on specific protein binding. J. Biol. Chem., 269, 26801-26805.
20. Weidner, D. A., Valdez, B. C., Henning, D., Greenberg, S. and Busch, H. (1995) Phosphorothioate oligonucleotides bind in a non sequence-specific manner to the nucleolar protein C23/nucleolin. FEBS Lett., 366, 146-150.
21. Abdul-Manan, N. and Williams, K. R. (1996) hnRNP A1 binds promiscuously to oligoribonucleotides: utilization of random and homo-oligonucleotides to discriminate sequence from base-specific binding. Nucleic Acids Res., 24, 4063-4070.
22. Liang, X. H., Shen, W., Sun, H., Prakash, T. P. and Crooke, S. T. (2014) TCP1 complex proteins interact with phosphorothioate oligonucleotides and can co-localize in oligonucleotide-induced nuclear bodies in mammalian cells. Nucleic Acids Res., 42, 7819-7832.
23. Vickers, T. A. and Crooke, S. T. (2014) Antisense oligonucleotides capable of promoting specific target mRNA reduction via competing RNase H1-dependent and independent mechanisms. PLoS One, 9, e108625.
24. Shen, W., Liang, X. H. and Crooke, S. T. (2014) Phosphorothioate oligonucleotides can displace NEAT1 RNA and form nuclear paraspeckle-like structures. Nucleic Acids Res., 42, 8648-8662.
25. Liang, X. H. and Crooke, S. T. (2013) RNA helicase A is not required for RISC activity. Biochim. Biophys. Acta, 1829, 1092-1101.
26. Liang, X. H. and Crooke, S. T. (2011) Depletion of key protein components of the RISC pathway impairs pre-ribosomal RNA processing. Nucleic Acids Res., 39, 4875-4889.
27. Swayze, E. E. and Bhat, B. (2008) The medicinal Chemistry of Oligonucleotides. In: Crooke, ST (ed). Antisense Drug Technology-Principles, Strategies, and Applications. 2nd edn. CRC Press, Boca Raton, FL. pp. 143-182.
28. Yu, Y. T., Shu, M. D. and Steitz, J. A. (1997) A new method for detecting sites of 2'-O-methylation in RNA molecules. RNA, 3, 324-331.
29. Jin, S. and Weaver, D. T. (1997) Double-strand break repair by Ku70 requires heterodimerization with Ku80 and DNA binding functions. EMBO J., 16, 6874-6885.
30. Conesa, C. and Acker, J. (2010) Sub1/PC4 a chromatin associated protein with multiple functions in transcription. RNA Biol., 7, 287-290.
31. Li, S., Kuhne, W. W., Kulharya, A., Hudson, F. Z., Ha, K., Cao, Z. and Dynan, W. S. (2009) Involvement of p54 (nrb), a PSF partner protein, in DNA double-strand break repair and radioresistance. Nucleic Acids Res., 37, 6746-6753.
32. Wolin, S. L. and Cedervall, T. (2002) The La protein. Annu. Rev. Biochem., 71, 375-403.
33. Okuwaki, M. (2008) The structure and functions of NPM1/Nucleophosmin/B23, a multifunctional nucleolar acidic protein. J. Biochem., 143, 441-448.
34. Liang, X. H., Vickers, T. A., Guo, S. and Crooke, S. T. (2011) Efficient and specific knockdown of small non-coding RNAs in mammalian cells and in mice. Nucleic Acids Res., 39, e13.
35. Liang, X. H., Hart, C. E. and Crooke, S. T. (2013) Transfection of siRNAs can alter miRNA levels and trigger non-specific protein degradation in mammalian cells. Biochim. Biophys. Acta, 1829, 455-468.
36. Maggi, L. B. Jr., Kuchenruether, M., Dadey, D. Y., Schwope, R. M., Grisendi, S., Townsend, R. R., Pandolfi, P. P. and Weber, J. D. (2008) Nucleophosmin serves as a rate-limiting nuclear export chaperone for the Mammalian ribosome. Mol. Cell. Biol., 28, 7050-7065.
37. Yu, Y., Maggi, L. B. Jr, Brady, S. N., Apicelli, A. J., Dai, M. S., Lu, H. and Weber, J. D. (2006) Nucleophosmin is essential for ribosomal protein L5 nuclear export. Mol. Cell. Biol., 26, 3798-3809.
38. Bharadwaj, A., Bydoun, M., Holloway, R. and Waisman, D. (2013) Annexin A2 heterotetramer: structure and function. Int. J. Mol. Sci., 14, 6259-6305.
39. Song, J. Y., Lim, J. W., Kim, H., Morio, T. and Kim, K. H. (2003) Oxidative stress induces nuclear loss of DNA repair proteins Ku70 and Ku80 and apoptosis in pancreatic acinar AR42J cells. J. Biol. Chem., 278, 36676-36687.
40. Manzoni, M., Monti, E., Bresciani, R., Bozzato, A., Barlati, S., Bassi, M. T. and Borsani, G. (2004) Overexpression of wild-type and mutant mucolipin proteins in mammalian cells: effects on the late endocytic compartment organization. FEBS Lett., 567, 219-224.
41. Geary, R. S., Yu, R. Z., Siwkoswki, A. and Leivin, A. A. (2008) Pharmacokinetic/Phar, acodynamic Properties of Phosphorothioate 2'-O-(2'Methoxyethyl)-Modified Antisense Oligonucleotides in Animals and Man. In: Crooke, ST (ed). Antisense Drug Technology-Principles, Strategies, and Applications. CRC Press, Boca Raton, FL, pp. 305-326.
42. Yaniv, M. and Gros, F. (1969) Studies on valyl-tRNA synthetase and tRNA from Escherichia coli. 3. Valyl-tRNA synthetases from thermosensitive mutants of Escherichia coli. J. Mol. Biol., 44, 31-45.
43. Morel, E. and Gruenberg, J. (2009) Annexin A2 binding to endosomes and functions in endosomal transport are regulated by tyrosine 23 phosphorylation. J. Biol. Chem., 284, 1604-1611.
44. Zelphati, O. and Szoka, F. C. Jr. (1996) Mechanism of oligonucleotide release from cationic liposomes. Proc. Natl. Acad. Sci. U. S. A., 93, 11493-11498.
45. Bayfield, M. A., Kaiser, T. E., Intine, R. V. and Maraia, R. J. (2007) Conservation of a masked nuclear export activity of La proteins and its effects on tRNA maturation. Mol. Cell. Biol., 27, 3303-3312.
46. Bachmann, M., Pfeifer, K., Schroder, H. C. and Muller, W. E. (1990) Characterization of the autoantigen La as a nucleic acid-dependent ATPase/dATPase with melting properties. Cell, 60, 85-93.
47. Naeeni, A. R., Conte, M. R. and Bayfield, M. A. (2012) RNA chaperone activity of human La protein is mediated by variant RNA recognition motif. J. Biol. Chem., 287, 5472-5482.